Blackstone Life Sciences today announced the launch of Anthos Therapeutics Inc. (“Anthos”), a new biopharmaceutical company focused on advancing next-generation targeted therapies for high-risk... read more
Blackstone Life Sciences today announced the launch of Anthos Therapeutics Inc. (“Anthos”), a new biopharmaceutical company focused on advancing next-generation targeted therapies for high-risk... read more
This morning, starting at approximately 10:15 AM ET, the United States Senate Finance Committee is holding a special hearing on drug pricing. Going before the Committee will be seven... read more
Xynomic Pharma, a clinical stage US-China oncology drug development company, and Bison Capital Acquisition Corp. (Nasdaq: BCAC) jointly announced on 2/25/19 the dosing of the first South Korean... read more
Alkermes plc (Nasdaq: ALKS) and Biogen Inc. (Nasdaq: BIIB) announced on 2/25/19 that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for... read more
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, announced on 2/25/19 that given the increasing viability of Valve-in-Valve (ViV) procedures, it has added new safety and... read more